Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 8, 2011
[Ruptured aneurysm of a posterior inferior pancreaticoduodenal artery associated with duodenal stenosis after transcatheter arterial embolization]Kenta Yamamoto, Takashi Kumada, Seiki Kiriyama, et al.Journal of Hepatology|February 24, 2009
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levelsTakashi Kumada, Hidenori Toyoda, Seiki Kiriyama, et al.Journal of Medical Virology|July 22, 2010
An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.Journal of Hepatology|November 6, 2012
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysisTakashi Kumada, Hidenori Toyoda, Toshifumi Tada, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 2, 2010
Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin in patients with HCV genotype 1bHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2005
Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapyHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.Journal of Medical Virology|January 20, 2009
Long-term follow-up of patients with hepatitis C with a normal alanine aminotransferaseTakashi Kumada, Hidenori Toyoda, Seiki Kiriyama, et al.Journal of Medical Virology|June 25, 2009
Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alphaHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.Cancer|May 26, 2004
Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in JapanHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.Journal of Gastroenterology|October 8, 2010
High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with HCV genotype 1bHidenori Toyoda, Takashi Kumada, Seiki Kiriyama, et al.Pageof 5